Career history of William W. Freimuth
Former positions of William W. Freimuth
| Companies | Position | Start | End |
|---|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 15/04/2009 | 22/08/2011 |
| Corporate Officer/Principal | 22/08/2011 | 01/10/2012 | |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
Training of William W. Freimuth
| State University of New York at Buffalo | Doctorate Degree |
| Michigan State University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
- Stock Market
- Insiders
- William W. Freimuth
- Experience
